Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Quanterix Corporation

< Previous 1 2 3 Next >
Quanterix’ Second Quarter 2022 Earnings Conference Call
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Launches First pTau-181 Plasma Laboratory Developed Test for Clinical Diagnostic and Research Applications in the U.S.
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Announces Appointment of Karen A. Flynn to Board of Directors
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Corporation Releases Operating Results for First Quarter 2022
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Corporation to Release First Quarter 2022 Financial Results on May 10, 2022
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix’ Simoa® Technology Powers Large, International Comprehensive Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Disease Activity in Multiple Sclerosis (MS) Patients
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Receives Funding from the Alzheimer’s Drug Discovery Foundation to Accelerate Alzheimer’s Disease Diagnostic Plasma Test Development
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Corporation to Release Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix to Participate in the SVB Leerink Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
Tickers QTRX
UK Dementia Research Institute Biomarker Factory Powers Alzheimer’s Disease Breakthroughs with Quanterix Simoa® Technology
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Provides Operational and Preliminary Financial Highlights
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix to Present at 40th Annual J.P. Morgan Healthcare Conference
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Recognized as a Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500™
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix’ Simoa® Technology Powers Advances in Alzheimer’s Disease Research Presented at 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Co-Inventor of Simoa® David Walt Receives Kabiller Prize in Nanoscience and Nanomedicine
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181 Assay for Alzheimer’s Disease
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Hosts Webinar with Leading Pathologist from Emory Medical Laboratories
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix to Host Webinar with Leading Pathologist from Emory Medical Laboratories: “COVID-19 Testing in a Residential University Setting: Implementation, Insights, and Learnings”
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Releases Statement
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix to Participate in the Canaccord Genuity 41st Annual Growth Conference
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Corporation Releases Operating Results for Second Quarter of 2021
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Corporation to Release Second Quarter 2021 Financial Results on Aug. 5, 2021
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Appoints Michael Doyle as Chief Financial Officer
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix’ Simoa Technology Powers Largest and Most Diverse Global Investigation of Plasma Neurofilament Light’s Role in Dementia Diagnosis
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference and Appear on the June 3 Episode of The Bio Report
From Quanterix Corporation
Via Business Wire
Tickers QTRX
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.